These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32420069)

  • 1. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
    Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
    Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative expression of zebrafish lats1 and lats2 and their implication in gastrulation movements.
    Chen CH; Sun YH; Pei DS; Zhu ZY
    Dev Dyn; 2009 Nov; 238(11):2850-9. PubMed ID: 19842174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
    Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
    Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LATS tumor suppressor: a new governor of cellular homeostasis.
    Visser S; Yang X
    Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Significance of Large Tumor Suppressor (
    Son MW; Song GJ; Jang SH; Hong SA; Oh MH; Lee JH; Baek MJ; Lee MS
    J Gastric Cancer; 2017 Dec; 17(4):363-373. PubMed ID: 29302376
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.
    Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X
    Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of LATS family proteins in ovarian tumors and its significance.
    Xu B; Sun D; Wang Z; Weng H; Wu D; Zhang X; Zhou Y; Hu W
    Hum Pathol; 2015 Jun; 46(6):858-67. PubMed ID: 25841306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in serous ovarian cancer is not associated with LATS expression.
    Montavon C; Stricker GR; Schoetzau A; Heinzelmann-Schwarz V; Jacob F; Fedier A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2737-2749. PubMed ID: 31586262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.
    Furth N; Aylon Y
    Cell Death Differ; 2017 Sep; 24(9):1488-1501. PubMed ID: 28644436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.
    Ito T; Nakamura A; Tanaka I; Tsuboi Y; Morikawa T; Nakajima J; Takai D; Fukayama M; Sekido Y; Niki T; Matsubara D; Murakami Y
    Cancer Sci; 2019 Jul; 110(7):2284-2295. PubMed ID: 31069869
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lats2, a putative tumor suppressor, inhibits G1/S transition.
    Li Y; Pei J; Xia H; Ke H; Wang H; Tao W
    Oncogene; 2003 Jul; 22(28):4398-405. PubMed ID: 12853976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LATS1 tumor suppressor regulates G2/M transition and apoptosis.
    Xia H; Qi H; Li Y; Pei J; Barton J; Blackstad M; Xu T; Tao W
    Oncogene; 2002 Feb; 21(8):1233-41. PubMed ID: 11850843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.
    Li ZG; Fu XM; Chai CY; Sun FF; Xiao FF; Huang YX; Yao K; Chen JP; Hou Y
    Chin Med J (Engl); 2020 Aug; 133(16):1943-1951. PubMed ID: 32826458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.
    Chan EH; Nousiainen M; Chalamalasetty RB; Schäfer A; Nigg EA; Silljé HH
    Oncogene; 2005 Mar; 24(12):2076-86. PubMed ID: 15688006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
    Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
    Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.